MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Genentech, Inc. (Narrative) (Details)	1 Months Ended
	Aug. 31, 2024 USD ($) performanceObligation	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Oct. 31, 2024 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Deferred revenues		$ 899,000	$ 7,556,000
Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Royalty obligation term	10 years
License | Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Contract with customer liability	$ 40,000,000.0			$ 10,000,000.0
Variable consideration amount	1,900,000,000
Remaining performance obligation amount	$ 50,000,000.0
Number of performance obligations | performanceObligation	2
Deferred revenues		$ 0
License, Technology Transfer | Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Contract with customer liability	$ 10,000,000.0